Difference between revisions of "LncRNAWiki:Bladder-cancer"
| Line 98: | Line 98: | ||
|G2E3 antisense RNA 1 | |G2E3 antisense RNA 1 | ||
|Bladder cancer | |Bladder cancer | ||
| + | |- | ||
| + | |bladder-cancer | ||
| + | |''SNHG26'' | ||
| + | |[[SNHG26]] | ||
| + | |AC005682.5 | ||
| + | |small nucleolar RNA host gene 26 | ||
| + | |Bladder urothelial carcinoma | ||
|} | |} | ||
Revision as of 07:22, 28 June 2017
| Cancer | Name | Transcript ID | Alias | Description | Other_Disease |
|---|---|---|---|---|---|
| bladder-cancer | MALAT1 | ENST00000534336.1 | HCN, "hepcarcin", LINC00047, "long intergenic non-protein coding RNA 47", MALAT-1, mascRNA, "metastasis associated in lung adenocarcinoma transcript 1", NCRNA00047, NEAT2, "non-protein coding RNA 47", "nuclear enriched abundant transcript 2", "nuclear paraspeckle assembly transcript 2 (non-protein coding)", PRO1073, ENSG00000251562 | metastasis associated lung adenocarcinoma transcript 1 (non-protein coding) | _ |
| bladder-cancer | TUG1 | NONHSAT084827 | ENSG00000253352 | taurine up-regulated gene 1 | _ |
| bladder-cancer | BLACAT1 | BLACAT1 | linc-UBC1,LINC00912, onco-lncRNA-30 | bladder cancer associated transcript 1 (non-protein coding) | bladder cancer |
| bladder-cancer | ZEB2-AS1 | NONHSAT074775 | Zeb2NAT, ENSG00000238057 | Zeb2 natural antisense transcript | bladder cancer |
| bladder-cancer | AATBC | AATBC | N/A | apoptosis associated transcript in bladder cancer | bladder cancer |
| bladder-cancer | MDC1-AS1 | MDC1-AS1 | MDC1-AS | MDC1 antisense RNA 1 | bladder cancer |
| bladder-cancer | H19 | NONHSAT017465 | Q96MK8,ENSG00000130600 | "H19, imprinted maternally expressed transcript (non-protein coding)" | "bladder cancer, breast cancer, cervical cancer, choricarcinoma, colon cancer, Congenital hyperinsulinism, Esophageal squamous cell cancer, gastric cancer, germ cell tumor, gestational choriocarcinoma, glioblastoma, glioma, growth restriction, hematopoiesis, infertility, kidney cancer, liver cancer, lung cancer, Marek's disease, Medulloblastoma, melanoma, Meningioma, Mullerian aplasia, myeloproliferative polycythaemia vera, neural tube defects, neuroblastoma, obesity, ovarian cancer, pheochromocytoma, pituitary adenoma, Prader-Willi syndrome, pre-eclampsia, prostate cancer, Silver-Russell syndrome, Wiedemann-Beckwith syndrome, Wilms' tumor" |
| bladder-cancer | MEG3 | NONHSAT039745 | Gtl2, ENSG00000214548 | maternally expressed 3 (non-protein coding) | _ |
| bladder-cancer | XIST | NONHSAT137541 | ENSG00000229807 | X inactive-specific transcript | _ |
| bladder-cancer | SNHG16 | NONHSAT056039 | ncRAN | small nucleolar RNA host gene 16 | bladder cancer, colorectal cancer |
| bladder-cancer | UCA1 | lnc-OR10H5-1:1 | UCA1a, CUDR, UCAT1, LINC00178, NCRNA00178, GCAP2, GUCA1B, GUCA2, RP48, ENSG00000214049 | urothelial cancer associated 1 (non-protein coding) | _ |
| bladder-cancer | DRAIC | DRAIC | N/A | "downregulated RNA in cancer, inhibitor of cell invasion and migration" | prostate cancer, bladder cancer, low-grade gliomas, lung adenocarcinoma, stomach adenocarcinoma, renal clear cell carcinoma, hepatocellular carcinoma, skin melanoma |
| bladder-cancer | G2E3-AS1 | G2E3-AS1 | CAT1647 | G2E3 antisense RNA 1 | Bladder cancer |
| bladder-cancer | SNHG26 | SNHG26 | AC005682.5 | small nucleolar RNA host gene 26 | Bladder urothelial carcinoma |
